Quick Answer: A useful cosmetic factory audit checklist connects every question to evidence and a decision. Review site scope, personnel, materials, equipment, production, testing, release, traceability, complaints and changes. Record gaps, owners and closure evidence rather than treating a ticked form as proof of conformity.
Use this checklist as a working record
This checklist is for a beauty brand assessing a proposed cosmetic production site. Add the site name, address, audit date, product families, markets, auditor and acceptance criteria at the top of your working copy. For every row, record the sample examined, document reference, factual observation, responsible person and due date. A tick without supporting evidence is difficult to defend later.
Use pass, gap, not examined and not applicable as separate results. Explain every exclusion. A process outsourced to another company is not automatically irrelevant: record the handoff, who qualifies the provider and how records remain available. If the manufacturer will mix but another site will fill, the checklist should identify both operators and the quality responsibilities between them.
The FDA cosmetic GMP inspection checklist discusses facility conditions, equipment, personnel, raw materials, production, laboratory controls and records. The NSAI ISO 22716 catalogue summary describes cosmetic GMP guidance for production, control, storage and shipment. These sources inform the questions below; this buyer tool is not the full standard, a regulator inspection or a certification assessment. For the commercial background, read our OEM and ODM guide.
| Control question | Manufacturer provides evidence | Brand reviewer evaluates and acts |
|---|---|---|
| Are site activities and subcontractors identified? | Process map, legal site details and outsourcing list | Unreviewed activities: define scope before approval |
| Can personnel explain hygiene and access rules? | Current instruction, relevant training and observed practice | Contamination risk: investigate differences |
| Are areas suitable for the intended work? | Product flow, storage conditions and visible housekeeping | Mix-up or contamination risk: assess affected operations |
| Does each material have clear identity and status? | Receipt example, supplier lot, status label and release record | Wrong input risk: hold unclear stock |
| Are rejected and quarantined materials controlled? | Physical segregation or effective access controls | Unintended use risk: verify disposition |
| Is equipment ready for the selected product? | Identity, cleaning record, maintenance and calibration status | Unreliable process: assess impact before use |
| Is water appropriate and monitored where used? | System description, specifications, sampling and trend review | Microbial risk: seek competent technical assessment |
Check the proposed product rather than a generic showroom
Select an actual product family relevant to the order and trace one completed batch. Compare the formula revision, material lots, equipment, processing instructions and packaging specification. If the site has never made the proposed type of product, record that limitation and ask what development and qualification work will establish capability. A polished sample on a meeting table cannot answer those questions.
Look at materials under different statuses. Ask the operator how a newly arrived ingredient becomes available for use, how damaged containers are handled and how expiry or retest dates are controlled. Select a material yourself where access permits. Compare what is on the shelf with what the inventory record says. Investigate mismatches before assigning a pass.
For equipment, choose items that affect the product decision: scales used for small additions, temperature instruments, mixers and filling controls may have different consequences if inaccurate. Ask how maintenance and calibration failures are assessed for previously manufactured batches. “The equipment is serviced” is incomplete unless the relevant item, date, result and response can be connected.
| Sequence milestone and question | Sample to examine | Follow-up decision |
|---|---|---|
| Weighing: is the correct formula version used? | Controlled instruction and selected dispensing entries | Resolve version or quantity discrepancies |
| Manufacturing: are key parameters recorded? | Time, temperature or other relevant process records | Assess whether execution can be demonstrated |
| Holding: is bulk identified and protected? | Container status, hold conditions and allowed duration | Assess contamination and mix-up exposure |
| Filling: are line clearance and pack checks effective? | Previous product clearance and current component checks | Investigate label or component substitution risk |
| Testing: are results linked to agreed specifications? | Sample ID, method, specification version and result | Resolve uncertain or atypical results |
| Release: who authorises disposition? | Authorised signature and deviation review | Do not accept an unexplained release decision |
| Dispatch: can finished lots be traced? | Lot, quantity, customer and transport records | Require a trace exercise when gaps remain |
Ask how exceptions are handled
A complete batch file should tell a coherent story, including deviations. Ask the manufacturer to show an example of an unexpected result, process interruption or packaging error. Check how the event was contained, how potentially affected stock was identified and who decided the next step. An assurance that problems never happen is not a substitute for an effective investigation system.
Where results fail a specification or appear atypical, request the investigation record and the rationale for any retest, resample or disposition. The technical details require competent review. Do not accept repeated testing until a desirable result appears without understanding the investigation. Equally, do not declare a serious failure from a single number without checking the method, sample and applicable specification.
Ask for a change example involving a material supplier, formula, process parameter, package or subcontractor. Determine whether the change was assessed before implementation and whether the brand would be notified under the agreement. The consequence may extend beyond the factory: stability evidence, artwork, product files or destination filings can need reassessment by the responsible role.
| Requirement or control | Manufacturer evidence | Brand action before acceptance |
|---|---|---|
| Agreed cosmetic GMP basis | Relevant site scope and operating records | Define criteria and evaluate the gaps |
| Destination obligations | Accurate formula and manufacturing information | Coordinate legal and safety review with local roles |
| Complaint investigation access | Lot records, retained evidence and named contacts | Set escalation and response expectations |
| Change notification | Controlled change process and notification record | Approve contractual notice and review triggers |
| Corrective action effectiveness | Cause analysis and subsequent implementation examples | Verify closure or retain the restriction |
| Traceability and market action support | Trace exercise and distribution connections | Test contact routes and assigned decisions |
Review laboratory and product evidence with the right expertise
Check that test records identify the product or batch, sampling date, specification and responsible reviewer. Ask what work is performed internally and what is contracted to an outside laboratory. For outsourced testing, examine how the provider is selected and how results are received and reviewed. A laboratory report is useful only when its relevance to the selected sample and decision is clear.
Microbiological quality, preservation performance, stability and packaging compatibility answer different questions. Determine which evidence is appropriate to the actual formula, intended use, package and market. A routine batch result does not automatically establish shelf life or preservation adequacy. Have qualified technical staff assess the study design and interpretation; the purchasing checklist should flag missing or mismatched evidence.
Review trends as well as isolated results. Ask how the site notices recurring issues in environmental or water monitoring where relevant, complaints, rejected materials and production deviations. A trend with repeated small excursions can warrant investigation even when the presentation focuses on individual passing results. Record what period was reviewed and what information was unavailable.
Assess document control, training and complaint readiness
Select a procedure used on the shop floor and compare it with the controlled version. Ask staff how obsolete instructions are removed and how revisions reach the people doing the work. Training records should connect to the role and changed task, with an appropriate check that the person can perform it. A signature sheet alone does not explain whether a revised practice is understood.
For complaints, trace one example from receipt to investigation, response and any action. Check whether manufacturing records and retained evidence can be retrieved within the agreed period. Ask who communicates with the brand and how urgent product concerns are escalated. A recall or withdrawal decision involves destination requirements and assigned responsible parties; the factory’s role should be defined in advance.
Conduct a practical trace question: given a finished lot, which material lots and dispatches can be identified? Where appropriate, reverse the exercise from an ingredient lot to affected finished products. Record the elapsed time, missing links and exclusions. The goal is a usable chain of evidence rather than a claim that a template proves full traceability for every transaction.
Turn the completed checklist into a supplier decision
Discuss observations before leaving and distinguish confirmed gaps from questions requiring additional evidence. Write each finding with the criterion, factual sample and potential consequence. Agree severity definitions before scoring. Avoid letting a total score obscure an unresolved issue that could affect product safety, identity or traceability. One significant gap may justify restricting the relevant manufacturing scope.
Require a response proportionate to each finding: immediate containment where needed, impact assessment, cause, corrective action, owner and deadline. Identify what evidence will demonstrate effectiveness. A revised procedure may be one part of the answer; completed subsequent records or a follow-up observation may still be needed. Keep actions open when implementation cannot be demonstrated.
The final record should state accepted scope, conditions, unresolved risks and reassessment triggers. The manufacturer operates and documents the production system. The brand defines supplier acceptance and coordinates product safety, claims, labels and market readiness with qualified responsible roles. The European Commission harmonised standards page supplies EU standards context, but a supplier checklist does not confer market access.
Use the compliant manufacturer selection guide to place the findings in the sourcing decision and the certificate guide to review supporting documents. To discuss a specific project, send the product and market brief together with the unresolved checklist items. This article does not claim that MOOYAM or any named factory has passed this audit.
| Destination context | Manufacturing audit focus | Separate market review |
|---|---|---|
| European Union | Assess relevant cosmetic GMP evidence and the actual manufacturing scope; review EN ISO 22716 context | The responsible person coordinates applicable product safety, file, notification and labelling duties |
| United States | Use relevant FDA cosmetic GMP inspection topics as evidence questions and check the current applicable framework | Confirm current facility, product, safety and responsible-person obligations for the arrangement; an audit is not FDA approval |
| Other intended markets | Identify locally relevant manufacturing criteria before assigning a conformity conclusion | Have qualified local roles verify classification, claims, filings and other applicable conditions |
Frequently asked questions
Is this checklist an ISO 22716 certification checklist?
No. It is a practical buyer tool informed by public GMP sources. A formal assessment requires the applicable criteria, competent assessors and the relevant assessment process.
Should every question receive a yes or no answer?
Record evidence and allow not examined or not applicable with reasons. A forced yes or no can hide scope limitations and unresolved questions.
What if the factory refuses to share confidential records?
Agree controlled access, redaction or supervised review where possible. If evidence remains unavailable, document the limitation and its effect on supplier acceptance.
Can a high checklist score outweigh a serious finding?
A score should not cancel a significant unresolved product or traceability risk. Apply agreed severity and acceptance criteria to the actual finding.
When should a brand repeat the checklist?
Set a schedule proportionate to risk and review sooner after significant changes, serious complaints, recurring deviations or corrective actions requiring follow-up.
Last reviewed: 30 October 2026. General sourcing and quality planning information, not product specific legal, safety or certification advice. Confirm applicable requirements and decisions with qualified advisers.